Read + Share
Peters S, Gadgeel SM, Mok T, Nadal E, et al. Entrectinib in ROS1-positive advanced non-small cell lung cancer: the phase 2/3
BFAST trial. Nat Med 2024 Jun 19. doi: 10.1038/s41591-024-03008.
PMID: 38898120
|
 |
|
Peters S, Gadgeel SM, Mok T, Nadal E, et al. Entrectinib in ROS1-positive advanced non-small cell lung cancer: the phase 2/3
BFAST trial. Nat Med 2024 Jun 19. doi: 10.1038/s41591-024-03008.
PMID: 38898120
|
|
|
|